These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5156964)

  • 1. The activated coagulation time test as a control for heparin therapy.
    Cho P; Bonilla-Linero F; Yim E
    Hawaii Med J; 1971; 30(6):474-7. PubMed ID: 5156964
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory control of heparin therapy with the activated partial thromboplastin time test.
    Degnan TJ; Karasik S; Lenahan J
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):390-6. PubMed ID: 4979988
    [No Abstract]   [Full Text] [Related]  

  • 3. The laboratory control of heparin therapy.
    Estes JW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):58-65. PubMed ID: 808391
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

  • 6. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated partial thromboplastin time test in heparin therapy. A study.
    Simmons A; Cross DE
    Mo Med; 1969 Jun; 66(6):430-3. PubMed ID: 5771362
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monitoring heparin therapy].
    Wettendorff P
    Rev Med Brux; 1983 Jan; 4(1):27-31. PubMed ID: 6836204
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood coagulation analyzers.
    Health Devices; 1997 Aug; 26(8):296-332. PubMed ID: 9283920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The biologic control of long-term heparin therapy in the light of 115 cases of patients treated with subcutaneous calcium heparinate].
    Migne J; Monteil R
    Angeiologie; 1967; 19(5):27-31. PubMed ID: 5621969
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized methods for heparin therapy.
    Soloway HB
    N Engl J Med; 1973 Aug; 289(8):429-30. PubMed ID: 4719832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activated coagulation time under heparin therapy in surgical diseases (author's transl)].
    Matsuda M; Tatsuta N; Aoshima M; Nagai T; Daitoh N
    Nihon Geka Hokan; 1977 Mar; 46(2):113-20. PubMed ID: 561580
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of heparin in the early post-traumatic period in burns and hemorrhage].
    Kil'diushov AN
    Anesteziol Reanimatol; 1994; (5):26-8. PubMed ID: 7893070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BaSon test: a rapid bedside test for control of heparin therapy.
    Baden JP; Sonnenfield M; Ferlic RM; Sellers RD
    Surg Forum; 1971; 22():172-4. PubMed ID: 5121343
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.